Skip to main content

Advertisement

Figure 3 | BMC Research Notes

Figure 3

From: Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test – two case reports and a review of the literature

Figure 3

Dynamic liver function assessment by LiMAx and Indocyanine green plasma disappearance rate in Case 2. Patients’ liver function capacity measured by LiMAx was reduced by 24% after chemotherapy. Four weeks after cessation of FOLFOX the patient had already regained former liver function. ICG PDR showed no clear trend. pre-Chemo – prior to chemotherapy, post-Chemo – after cessation of chemotherapy, 4 weeks – 4 weeks after cessation of chemotherapy, 8 weeks – 8 weeks after cessation of chemotherapy.

Back to article page